文献速递骨显像与常规 SPECT

纵向数据集中Na[18F]氟化物PET/CT鉴别r-axSpA相关病变与退行性病变

Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[18F]Fluoride PET/CT in a longitudinal dataset of patients with radiographic axial spondyloarthritis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-10-09

研究纳入20例活动性放射学阳性中轴型脊柱关节炎(r-axSpA)患者,在生物治疗前及第12、52周行Na[18F]氟化物PET/CT,由两名盲法读者对中轴骨骼PET阳性病变评分分类。共检出276个视觉摄取病变,其中98个(36%)为r-axSpA病变、46个(17%)为退行性(D)病变;r-axSpA病变数从基线98个降至第12周67个(-32%)和第52周55个(-18%),D病变数随时间保持稳定。

要点

  • r-axSpA病变多位于胸椎(84%),D病变多位于腰椎(48%)。
  • 84%和88%的r-axSpA病变在基线至12周和52周显示摄取下降。
  • 多数D病变在随访期间显示摄取增加或轻度下降。

核心结论

  • 生物治疗期间,视觉分类的r-axSpA病变与D病变在病变数量和定量示踪剂摄取上呈现显著不同的变化。

研究设计与样本

  • 纳入20例活动性r-axSpA患者,在生物治疗前及第12、52周行Na[18F]氟化物PET/CT,由两名盲法读者评分分类,并以标准化摄取值(校正个体全血活性浓度,SUVAUC)定量评估摄取。

主要发现

  • 共检出276个视觉Na[18F]氟化物摄取病变,其中98个(36%)定义为r-axSpA病变,46个(17%)定义为D病变。
  • r-axSpA病变总数从基线98个降至第12周67个(-32%)和第52周55个(-18%),D病变数随时间保持稳定。
  • r-axSpA病变多数位于胸椎(84%),D病变多数位于腰椎(48%)。
  • 84%和88%的r-axSpA病变在基线至第12周和第52周显示Na[18F]氟化物摄取下降;多数D病变在基线至随访间显示摄取增加或轻度下降。

临床怎么用

  • 在r-axSpA患者生物治疗随访中,Na[18F]氟化物PET/CT上r-axSpA病变数量及定量摄取随治疗下降,而D病变稳定,有助于二者鉴别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate longitudinal changes of Na[18F]Fluoride uptake in the axial skeleton of patients with radiographic axial spondyloarthritis (r-axSpA) during biological treatment, focusing on r-axSpA and degenerative (D) lesions. METHODS: 20 active r-axSpA patients were included. Na[18F]Fluoride Positron Emission Tomography / Computed Tomography (PET/CT) scans were performed prior to, as well as 12 and 52 weeks after starting biological therapy. PET-positive lesions in the axial skeleton were scored and classified by two blinded readers. Quantitative Na[18F]Fluoride uptake was assessed by determination of standardized uptake values (SUV) corrected for individual integrated whole blood activity concentration (SUVAUC). RESULTS: A total of 276 lesions with visual Na[18F]Fluoride uptake were detected, of which 98 (36%) were defined as r-axSpA and 46 (17%) as D. The total number of r-axSpA lesions decreased from 98 at baseline to 67 at week 12 (-32%) and to 55 at week 52 (-18%), while the number of D lesions remained stable over time. The majority of r-axSpA lesions were observed in the thoracic spine (84%), while the majority of D lesions were observed in the lumbar spine (48%). Quantitatively, 84% and 88% of the r-axSpA lesions showed a decrease of Na[18F]Fluoride uptake between baseline and 12 and 52 weeks, respectively. In contrast, most D lesions either showed an increase or mild decrease between baseline and follow-up. CONCLUSION: Na[18F]Fluoride uptake in visually classified r-axSpA and D lesions in r-axSpA patients on PET/CT demonstrated a striking different change in both the number of r-axSpA lesions and quantitative tracer uptake herein versus D lesions while on biological treatment.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. de Jongh J, Groothuizen S, Zwezerijnen GJC, et al. Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[18F]Fluoride PET/CT in a longitudinal dataset of patients with radiographic axial spondyloarthritis. Eur J Nucl Med Mol Imaging. 2026. PMID: 42850434. doi:10.1007/s00259-026-08178-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。